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The integration of artificial intelligence models to
augment imaging modalities in pancreatic cancer
Xianze Wang, MDa, Wen Yuan Chung, MBBChBAO PhDb, Elon Correa, PhDc, Yi Zhu, PhDd,
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Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a limited number of effective treatments. Using
emerging technologies such as artificial intelligence (AI) to facilitate the earlier diagnosis and decision-making process represents one
of the most promising areas for investigation. The integration of AI models to augment imaging modalities in PDAC has made great
progression in the past 5 years, especially in organ segmentation, AI-aided diagnosis, and radiomics based individualized medicine.
In this article, we review the developments of AI in the field of PDAC and the present clinical position. We also examine the barriers to
future development and more widespread application which will require increased familiarity of the underlying technology among
clinicians to promote the necessary enthusiasm and collaboration with computer professionals.
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Introduction
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive
malignancy with no effective treatment when surgical resection is
not appropriate. The prognosis hasn’t significantly improved in
the past 3 decades[1] and in China, the incidence of PDAC ranks
9th among all cancers, with more than 100,000 patients
diagnosed each year. The mortality from PDAC ranks 6th and
it has become one of the leading causes of tumour related death.[1]
Presently the therapeutic strategies for PDAC remain limited and
surgery remains the only effective treatment with 5-year survival
rates only 8% for patients following potentially curative
surgery.[2] A number of different therapeutic options have been
investigated but the benefits of more recent treatments such as
immunotherapy, neoadjuvant chemotherapy and chemoradio-
therapy remain uncertain.[3] As a consequence, research into
novel approaches continues and it is recognised that the use of
emerging technologies to facilitate earlier diagnosis represents
one of the most promising areas for investigation. Recent
developments in the field of artificial intelligence applied to the
augmentation of imaging modalities are encouraging and it is
appreciated that we need to appreciate the potential and take full
advantage of the opportunities for interdisciplinary research to
improve the prognosis of patients with PDAC.
The idea of AI was originally suggested by McCarthy et al in
1955[4] and it was initially meant to allow machines to replicate
activities traditionally associated with human intellect including
logical reasoning, learning, pattern recognition, intuition and
deduction. Since AI and machine learning was envisaged the
concept has significantly expanded and the potential for
application in myriad fields, appreciated. Research facilitated
the development and expansion of AI from the original rule-
based models which could only pursue simple tasks to statistical
and learning based models which can investigate and recognize
patterns in massive data sets. AI has emerged as a mature
discipline with the goal of achieving human-like capabilities, in
particular autonomous development and learning. The progress
in AI has also occurred in parallel with developments in the
acquisition and management of “big data” and the hardware and
technology required for its application. The potential for the
integration of AI and big data and the subsequent applications in
healthcare are now widely appreciated and it is believed to offer
opportunities for a paradigm shift with a new era for clinical
practice in areas including health and well-being, early detection,
diagnosis, decision making, treatment, end of life care, research,
and training.
Definitions of AI are broad and are generally divided into
narrow AI which includes areas such as the interpretation of
video feeds, visual inspection and co-ordination with other
intelligent systems and general AI, which is the type of flexible,
adaptable intelligence capable of learning found in humans. AI is
now accepted as an overarching term for systems including
machine learning, neural networks and deep learning.
Traditional machine learning is often regarded as the “shallow-
layer learning method” which is where large amounts of data are
used by computer systems to learn how to carry out specific tasks
such as speech recognition. Traditional machine learning relies
on pattern recognition or statistical methods and requires
structured and historic data with prior knowledge of outcomes.
The common models and algorithms of machine learning include
a Department of Surgery, Peking Union Medical College Hospital, Chinese
Academy of Medical Science & Peking Union Medical College, Beijing, China,
b Department of Hepatobiliary and Pancreatic Surgery, Leicester General
Hospital, Leicester, c School of Computing, Science and Engineering, University
of Salford, Manchester, d Language Technology Lab, University of Cambridge,
Cambridge, UK
∗
Corresponding author: Ashley R. Dennison, Department of Hepatobiliary and
Pancreatic Surgery, Leicester General Hospital, Leicester, UK, LE5 4PW.
E-mail: ashley.dennison@uhl-tr.nhs.uk
Copyright © 2020 The Chinese Medical Association, Published by Wolters
Kluwer Health, Inc. under the CCBY-NC-ND license.
This is an open access article distributed under the terms of the Creative
Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-
ND), where it is permissible to download and share the work provided it is
properly cited. The work cannot be changed in any way or used commercially
without permission from the journal.
Journal of Pancreatology (2020) 3:4





logistics regression, random forest (RF),[5] support vector
machine (SVM),[6] expectation-maximization (EM)[7] and k-nearest
neighbour (KNN).[8]
Deep learning is a more recent AI development and often
referred to as a “deep-layer learning method” and is based on
artificial neural networks (ANN). ANNs were developed to
recognise patterns in data and are loosely modelled on the human
brain. They consist of a set of algorithms, based on a collection of
connected units or nodes referred to as artificial neurons. The
artificial “neurons” loosely model biological neurons and they
interpret sensory data which they then categorise and collate.
More complex neural networks contain more hidden layers and
as a consequence, more connections. The increasing complexity
which results from these additional layers, together with the
statistical weights and biases within the system enable the
networks to “learn” and identify complex patterns in large data
sets.
For the application of ANNs in image recognition, each
“neuron” of the input layer is responsible for extracting the
information contained in a specific region, while the weight of its
output will affect the activation of neurons in the next layer. All
neurons of a given layer are generating an output for the next
layer and if the output weight is low (for the overall picture) then
it will mean less for the overall picture and will be partially or
completely muted. The information gathered will be abstracted
into feature vectors by multiple transformations and nonlinear
mappings via a multi-layer structure, and finally condensed and
displayed in the output layer. ANNs are generally trained end-to-
end by iteratively optimizing a loss function which is one of the
important components of neural networks and is used to update
the weights of the neural net allowing an ANN to be trained.
Convolutional neural networks are a class of deep neural
networks most commonly applied to analysing visual imagery.
Convolutional networks are neural networks that use convolu-
tion in place of general matrix multiplication in at least one of
their layers. The name “Convolutional neural networks (CNN)”
is a consequence of the mathematical operation called convolu-
tion (an operation which has 2 functions as input but a single
function, describing how the input functions influence each other,
as the output) utilised by the networks. Fully convolutional
networks (FCNs) owe their name to their architecture, which is
built only from locally connected layers. The absence of a dense
layer in FCNs reduces the number of parameters and computa-
tion time and the network does not requiring any fixed number of
units at any stage so the original image size is not important.[9,10]
The field of deep learning and neural networks is complex and
rapidly expanding and is discussed in a comprehensive review by
Litjens et al.[9]
There has been a rapid expansion of the applications of AI to
medical images analysis over the last 5 years including the
investigation of pancreatic cancer using multi-organ segmenta-
tion based on spatially-divided probabilistic atlases of 3D
abdominal CT images for the detection and differential diagnosis
of PDAC, therapeutic effect monitoring and the prediction of
prognosis in individual patients. All of these techniques may also
be applied in image reconstruction, disease screening, endoscopic
navigation, conformal radiotherapy, individualized therapy, and
patient surveillance.
The application of AI in pancreas segmentation
The segmentation of pancreas and pancreatic lesions is one of the
most popular applications of AI in medical images and part of the
foundation of computer-aided diagnosis (CAD), tumour staging,
and radiotherapy contouring. To date the performances of
segmentation on liver, kidney, and spleen have exceeded 90% on
Dice Similarity Coefficient (DSC) (also called the Sørensen-Dice
coefficient a statistical method used to assess the similarity of 2
samples).[11,12] Although the pancreas is one of the most difficult
organs for parenchymal segmentation the accuracy is presently
approximately 74% on DSC and 60% of Jaccard Index (JI, also
known as the Jaccard similarity coefficient which is a statistical
model used to compare the similarities between sample sets)
(Table 1).
The anatomical and imaging features of the pancreas are
responsible for the preclusion of greater diagnostic accuracy. The
adjacent organs and adipose tissues surrounding the pancreas
have a similar attenuation to the gland itself resulting in indistinct
boundaries and the shape of pancreas is irregular with
considerable variation in size and anatomical disposition between
individuals. Lesions in the pancreas are also morphologically
diverse and frequently result in deformation of the gland further
confounding accurate and reproducible automated segmenta-
tion.
Multi-atlas registration and label fusion (MALF) is one of the
most popular strategies to achieve organ segmentation on
medical images (also called atlas-based segmentation). The
“atlas” is constructed from spatially aligned images with
the region of interest (ROI) identified and defined by physicians.
The labels on atlases are then used to guide the acquisition of
estimations on each voxel (a unit of graphic information which
defines a point in 3-dimensional space) and the labels are then
transferred to target images. The accuracy of MALF is excellent
but the process is complex and the production of the atlases and
required computational complexity limit the clinical application
of this technique.
Shimizu et al presented one of the earliest studies of pancreas
segmentation in 2007 and demonstrated a 35% JI by using the
atlas guided segmentation incorporating with an extended EM
algorithm. Subsequently in 2009 the same group improved the
results significantly achieving an average 57.9% JI.[13] In the
2009 study Shimizu et al improved the localization of the
pancreas via a 2-stage segmentation strategy, guided with a
patient-specific probabilistic atlas and the utilization of a
classifier ensemble to boost segmentation performance. During
the evolution of algorithms for MALF based strategies, Wolz
et al[11] introduced a coarse-to-fine weighting scheme on global,
organ and voxel level, and combined the multi-atlas registration
with a patch-based segmentation. Wang et al[14] employed
geodesic distances in patch selection during a KNN search
process (k-nearest neighbour algorithms work by calculating
distances between a query and all the examples in the data,
selecting the specified number examples [K] closest to the query),
which improved the tolerance in respect of registration errors. In
addition, Tong et al[12] improved the segmentation performance
by modifying the atlas selection process, proposing a voxel-wise
atlas selection strategy to capture the information from the target
image, and used a discriminative dictionary learning for a
segmentation (DDLS) method to deal with the high inter-subject
variation on abdominal CT images.
Limitations of the conventional intensity-based atlas relate to
the similar attenuation of surrounding structures and the
complex and crowded retroperitoneal space in which the
pancreas is located. In 2015, Okada et al[15] proposed a
prediction-based priors for pre-segmentation and an organ
correlation graph for spatial correction. Using this approach, the
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estimation was set free from supervised intensity information and
also achieved an accuracy of 73% on DSC. In a similar study in
2017, Karasawa et al[16] proposed a structure-based atlas
selection strategy in which the vessels around pancreas, including
the splenic and mesenteric veins, were used as landmarks. The
method employs a non-rigid registration and utilizes vessel
structure around the pancreas to select atlases with high
pancreatic resemblance to the unlabelled volume. Coarse-to-fine
pancreas segmentation was realized with EM algorithm and the
model was evaluated using 150 CT sets and achieved 78.5% in
DSC and 66.3% in JI, but unfortunately even with this technique
the runtimes were still 2 to 4hours per case.
Due to the complexity of MALF atlas generation and the
required computing power, methods based on artificial neural
networks (ANN) have become increasingly popular in the last
5 years[10] and ANNs (vide supra) underpin approaches to
pancreas segmentation. Roth et al[17] were one of the first groups
to apply CNN to pancreas segmentation and made significant
progress in automating the process. In his study, superpixel
(groups of pixels considered together based on similarities of
colour and other low-level properties) candidates of abdominal
regions were generated via feature extraction and random forest
classifier, and the retained superpixels were put into a 5-layer
CNN. The probability map was output and smoothed by using a
Gaussian kernel. Roth et al achieved a performance of 68% in
DSC and revealed the potential of CNN in pancreas segmentation
and a similar approach has been used by Farag et al.[18] A major
problem of CNN is that the feature maps size of target image will
be condensed during convolution and pooling, which caused the
loss of detailed information and clarity of the boundaries of the
ROI.
To address the loss of detail and edge of organ definition the
FCN architecture was proposed. FCN achieves semantic
segmentation via full convolutionalisation which is used to
maintain the features dimension, the up-sampling to regain the
image size, and the skip connection architecture to restore the lost
information. Roth et al subsequently proposed a holistically
nested convolutional network (HNN) architecture, which
combined the FCN with deep supervision and demonstrated
enhanced performance on edge detection. Roth’s model has
undergone considerable development and following a number of
iterations the DSC rose from 71.8%[19] to 78.01%,[20] and finally
81.3%.[21] There are other approaches to the problems produced
when confusion is caused by complex and variable backgrounds
and Yu et al have describe a technique using a Recurrent Saliency
Transformation Network with a course-to-fine approach using a
prediction from the first stage to identify a smaller input region
for the second stage.[22]
U-Net and V-Net are further adaptations of FCN and in 2018
Gibson et al[23] developed a deep FCN based registration-free
algorithm which achieved segmentation in a number of organs
including the pancreas. The dense connections and themulti-scale
Table 1
Studies and performances about pancreas segmentation.
Model/algorithm/method DSC (%) JI (%) Image source
Shimizu[60] 2007 MALF, extended EM About 35 CT
Shimizu[13] 2010 MALF, MadaBoost 57.9 CT
Chu[61] 2013 MALF 69.1±15.3 54.6 CT
Wolz[11] 2013 MALF, graph-cuts 69.6±16.7 55.5±17.1 CT
Okada[62] 2013 MALF, PLSR 71.8 59.2 CT
Wang[14] 2014 MALF, KNN 65.5±18.6 CT
Tong[12] 2015 MALF, DDLS 71.1±14.7 56.9±15.2 CT
Roth[17] 2015 CNN 68±10 CT
Roth[19] 2015 CNN 71.8±10.7 CT
Okada[15] 2015 MALF, PLSR 73.3±14.1 60.0±15.9 CT
Oda[63] 2016 MALF, regression forest 75.1±15.4 62.1 CT
Roth[20] 2016 HNN 78.01±8.2 CT
Cai[28] 2016 CNN 76.1±8.7 MRI
Shen[27] 2016 MALF 67.2±15.5 MRI
Saito[64] 2016 SSM 74.4±20.2 62.3±19.5 CT
Farag[18] 2017 CNN 70.7±13.0 57.9±13.6 CT





Karasawa[16] 2017 MALF, EM 78.5±14.0 66.3±15.5 CT
Fu[65] 2018 RCF 76.4±14.3 63.7±17.1 CT
Gibson[23] 2018 DenseVNet 78 CT
Roth[21] 2018 HNN 81.27±6.27 68.87±8.12 CT
Bobo[32] 2018 FCN 69.1 MRI
Oktay[25] 2018 U-net with attention gate 84±8.7, 83.1±3.8 CT
Yu[22] 2018 RNN 84.5±4.97 CT
Isensee[26] 2019 U-net-based 82 CT
Boers[24] 2020 Interactive U-net 78.1±8.7(automatic);
86.0(semi-automatic)
CT
Zheng[31] 2020 U-net 73.9(MRI); 84.4(CT) CT+MRI
He[66] 2020 CNN, MCMC 78.13 CT
Bagheri[67] 2020 CNN 78±8 CT
Liang[30] 2020 CNN 73±9 MRI
DenseVNet = dense V-network FCN; EM = expectation-maximization; HNN = holistically-nested convolutional neural networks; LSTM = long short-term memory network; MCMC = Markov chain Monte Carlo;
PLSR = partial least square regression; RFC = richer feature convolutional network; SSM = statistical shape model.
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V-net structure improve the performance of pancreas segmenta-
tion to 78% in DSC and achieved promising accuracy for the
digestive tract and associated organs. Consequently, Gibson et al
demonstrated the potential value of their model in supporting
intra-procedural navigation during interventions such as endo-
scopic retrograde cholangiopancreatography (ERCP). In a
further iteration an interactive 3D U-net method (iUnet) was
proposed by Boers et al,[24] in which the initial segmentation was
provided via U-net. The iUnet was fully trained to produce the
best possible initial segmentation. In interactive mode it was
additionally trained on a partial set of layers on user generated
scribbles and initial segmentation performance of iFCN and
iUnet compared on a 100CT dataset using dice similarity
coefficient analysis. Labelled voxels and the nearby regions of
uncertainty were re-weighted and put into the model for
retraining. The performance of iUnet surpassed the similar
approaches such as FCN and normal U-net. Moreover, the
interactive amendments not only achieved outstanding accuracy
of 86% in DSC, but also dramatically reduced the time required
to 8minutes, compared with the 87% DSC in 15minutes for
manual segmentation. The interactive method proposed by Boers
et al confirmed that prior knowledge from expert physicians is
required to improve the efficiency of the model, facilitate model
training and boost the performance of any AI applied to
pancreatic imaging. Different groups have further refined the
ability of a model to focus on target structures of varying shapes
and dimensions and Oktay et al describe a novel “Attention Gate
Model”. Models trained with AGs implicitly learn to suppress
irrelevant regions in an input image while highlighting salient
features useful for a specific task.[25] The design of solutions is
highly dependent on the properties of the dataset and the
hardware conditions. Isensee et al have developed an approach
which they have made publicly available as an open source tool.
nnU-Net is a deep learning framework that condenses current
domain knowledge and is able to autonomously takes the key
decisions needed to transfer a basic architecture to different
datasets and segmentation tasks.[26]
Progress has also been made in AI-based pancreas segmenta-
tion based on MRI images. Although MRI has not been widely
used for the diagnosis of pancreatic disease and pathology due to
the cost and time required, it is better suited for the identification
and delineation of peri-pancreatic adipose tissues, which is often
the major factor limiting the segmentation accuracy of imaging
modalities. Shen et al,[27] employed a MALF based strategy to
perform pancreas segmentation based on MRI images (67.2% in
DSC) but the overwhelming majority of studies were based on an
approach using ANN.
In 2016, Cai et al[28] used a 2-step CNN based method to
perform tissue detection and boundary delineation separately,
and achieved 76.1% DSC on MRI images. Later, they improved
the model and hybridized a convolutional long short-term
memory network to CNN in order to perform contextual
learning and smooth the neighbouring 2D images. Further studies
suggested that this novel architecture achieved a superior
accuracy using both MRI and CT images.[29] Subsequently,
Liang et al[30] analysed 37 sets of MRI from pancreatic cancer
patients and by using a square-window based CNN architecture
which reduced the time of gross tumour volume delineation to 10
seconds and also achieved comparable accuracy to experts. These
very promising results are likely to see this approach investigated
further and in particular to facilitate its application in MRI-
guided online adaptive radiation therapy for PDAC. Other
groups including Zheng et al[31] and Bobo et al[32] have also
investigated the use of U-net or FCN for MRI analysis and
achieved similarly promising accuracy.
The application of AI in the diagnosis of pancreatic
cancer
Pancreatic cancer is by far the most common malignancy of the
pancreas with the highest mortality. The retroperitoneal
anatomical position, relationship to adjacent organs and the
surrounding and intra-pancreatic vessels make accurate and
reliable imaging notoriously difficult. For this reason, the
application of AI to augment traditional expert analysis and
improve efficiency is very attractive particularly for the detection
of pancreatic cancer and the differential diagnosis of benign
pancreatic diseases.
Imaging of the pancreas is an essential pre-requisite for the
diagnosis of pancreatic cancer and similar to tumours in the lung
or liver, lesions in the pancreas often have a low attenuation and
lack a clear margin and separation from surrounding structures
making early detection extremely difficult even for experienced
radiologists. The majority of PDACs occur in the head and
uncinate process, which unfortunately is the most complicated
area anatomically andwhere adjacent tissues are most likely to be
invaded. It is this combination of factors which complicates the
preoperative assessment especially as pancreatic cancer can be
associated with other, often concomitant pancreatic diseases such
as intraductal papillary mucinous neoplasms (IPMN) which
further reduces the potential accuracy of any imaging modality.
Other benign conditions, particularly post-inflammatory prob-
lems such as mass forming pancreatitis which can also be
associated with PDAC can also reduce the potential diagnostic
accuracy. This complexity makes the assessment of pancreatic
imaging an ideal area to consider the use of AI to enable the
reliable, early identification of pancreatic cancer.
Typically, radiologists will consider tumour characteristics
revealed by any imaging modality holistically, including the size,
shape, location, Grayscale level, attenuation and uniformity and
considering all the characteristics together decide on the most
likely diagnosis based on their previous experience. Diagnostic AI
functions are generally implemented through texture and
radiomic analysis,[33] which simulates the workflow of a clinical
radiologist. The textural features of an image are characterized by
the spatial distribution of Gray levels in a neighbourhood, and
are extracted via structural, statistical, or modelling methods.
The role of radiomics is to contextualise the process by providing
high-dimensional and quantitative information on images and
decoding the radiomic biomarkers and phenotypes of tumours.
The early algorithms developed for PDAC recognition were
based on traditional machine learning methods, and support
vector machine algorithms (SVM) were the most popular. In
2012, He et al[34] used SVM to detect PDAC biomarkers from
spectrometry data and a 3 years later, Jiang et al[33] used an SVM
based model for PDAC classification where the Grayscale and
fractal dimension features from pancreatic images were extracted
and condensed to tensors. The tensors were then put into the
SVM which was optimized by the improved fruit fly optimal
algorithm (algorithms based on swarm intelligence are an
effective way of solving complex optimisation problems and
compared with traditional algorithms improve simplicity and
effectiveness) and a better classification performance of 97.14%
accuracy was achieved within 31seconds. In 2019, Hussein
et al[35] were able to accurately identify and diagnose IPMN by
SVM in a unsupervised manner and for the first time, Ren et al[36]
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combined imaging features and textural analysis to differentiate
mass forming pancreatitis (MFP) from PDAC. In this study,
conventional imaging features such as tumour location, shape,
and enhancement pattern, as well as the textural features such as
voxel intensities distribution, geometric features, and high-order
Gray information from the ROI were extracted and evaluated.
Further studies were able to demonstrate that, the textural
features conferred an improved better accuracy (96%) when
compared with conventional imaging features (84%), while the
multi-phase feature-combined model achieved the highest
accuracy (98%) in classifying these 2 pancreatic pathologies.
In addition to pancreatic cancer a number of groups have
explored the application of AI for the identification of pancreatic
cystic masses using traditional machine learning and demon-
strated that it was possible to achieve average accuracies and
AUC of 66% to 93% and 0.75 to 0.837.[37–41]
Deep learning methods such as CNN have also been employed
for PDAC detection and diagnosis. Liu et al[42] employed a faster
region-based CNN and analysed more than 6000 CT images
from 338 PDAC patients. Labelled CT images were converted
into convolutional feature maps for regression and classification
via a pre-trained VGG16 model (a model which achieves 92.7%
top-5 test accuracy in ImageNet, which is a dataset of over 14
million images belonging to 1000 classes) and the parameters
were adjusted and iterated continuously. Eventually, Liu’s model
was validated in a relatively large cohort and achieved 0.9632 in
AUC for PDAC detection, and the duration of diagnosis was only
20seconds for each patient. Unfortunately, the perception of
CNN (black-box characteristics) and the difficulty in under-
standing the underlying concepts have limited CNNs acceptance
by physicians. To address these issues Dmitriev et al[43] focused
on the decision making processes of an AI model and presented a
comparative eye-tracking experiment comparing AI and radiol-
ogists, in order to ensure that the features which influenced the
decision making process were explicit and transparent. In this
way Dmitriev and colleagues who achieved a 91.7% accuracy in
classifying different pancreatic lesions were also able to reveal
and explain the features of random forest and CNN models used
in the decision-making process. In addition, and more impor-
tantly, the decision-process visualized CAD system is easier to
interpret and consequently confers increased accessibility for
physicians.
PET/CT and MRI based AI models have also proved to be
effective in augmenting the diagnosis of PDAC and Li et al[44]
extracted major structure and location information from the ROI
on CT and PET images, and also incorporated metabolic features
such as standard uptake value (SUV) mean and variance. Those
features were further refined using a dual threshold principal
component analysis (DT-PCA) method in order to reduce the
feature dimension, and the hybrid SVM-RF algorithm was used
to fulfil the identification. By doing this, Li et al achieved a
96.47% accuracy for PDAC classification in 80 cases with a
95.23% sensitivity and 97.51% specificity. Zhang et al[45]
performed a radiomic analysis to differentiate PDAC from
autoimmune pancreatitis (AIP) and 251 features containing pixel/
voxel intensity, ROI morphological, and textural information
were extracted from both 2D and 3D PET and CT images.
Results demonstrated that 3D features were significantly more
accurate when compared with 2D features and that anatomical
information contained in CT scans was more discriminative than
metabolic features on PET scans. The best performance was
achieved via SVM-RFE feature selection (recursive feature
elimination) and Linear SVM classifier, in which the AUC was
0.93 and the diagnostic accuracy was 85% which was
comparable to expert clinical radiologists. For MRI, Gao
et al[46] analysed enhanced MRI images from 504 patients with
7 categories of pancreatic diseases which had been diagnosed by
radiologists. Lesion obtained MRI patches were prepared based
on the pathological results, and synthetic images of ROI from
each disease group used to train the CNNmodel. Finally, with the
help of the generative adversarial network and InceptionV4 (both
are CNN architectures), the AUC of pancreatic cancer and other
pancreatic diseases was 0.91 and 0.72 to 0.93 in validation.
The application of AI in individualized medicine
of pancreatic cancer
The considerable inter-tumour heterogeneity due to variations of
the genotype and phenotype is considered to be one of the main
factors contributing to the quite different biological behaviour.
These differences also underpin the rationale behind individual-
ized medicine and the belief that significant advances will result
from an approach that bases treatments on a comprehensive
understanding of this heterogeneity. Variations in tumours
resulting from gene mutations together with the genetic makeup
of patients determine the behaviour of the tumours and
individualised medicine relies on “multi-omics” data, which
generally refers to the genomic, transcriptomic, and proteomic
characteristics of tumours and patients. Unfortunately, the cost
and time pressures which these approaches impose on any
healthcare system are barriers to the widespread availability and
uptake of themselves.
A number of studies have demonstrated that the information
contained in radiomics may be the macroscopic expression of
tumours characteristics and that by analysing the information
contained in the images augmented with a variety of recent AI
techniques that sufficient data will not only facilitate appropriate
therapeutic response evaluation, and prognosis analysis but also
improve access to individualised medicine by ensuring it is cost
effective.
Qiu et al[47] conducted a machine learning based quantitative
texture analysis on the CT images from patients with PDAC.
They used the SVM to classify cases based on their textural
features and found that 18 features were significantly different
between patients with pathological high-grade and low-grade
PDAC while the clinical characteristics were less distinctive. Qiu
et al achieved an accuracy of 86% when make a pathological
prediction of PDAC according to radiomic information, which
may be used as a method for non-invasive preoperative
pathological evaluation to assist clinicians to formulate treatment
plans.
Kambakamba et al[48] adopted a similar approach and used
radiomics in an attempt to predict the risk of developing a
postoperative pancreatic fistula (POPF). They performed a
textural analysis on preoperative CT images from 110 patients
who had undergone a pancreatoduodenectomy. The textural
features were further condensed and demonstrated the ability to
detect fibrosis, lipomatosis, and intraoperative pancreatic
hardness. Comparing the predictive value, Kambakamba et al
concluded that texture analysis was more accurate (AUC=0.95)
than the original and alternative fistula risk scores (AUC=0.76
and 0.72, respectively) in predicting POPF and would provide a
superior guide, alerting clinicians to the need for postoperative
interventions in targeted patients.
AI has also been shown to a valuable aid when evaluating the
therapeutic effect and predicting the prognosis of PDAC patients,
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potentially guiding clinicians to ensure optimal treatment and
better surveillance. Cui et al[49] were one of the first groups to
perform a quantitative feature analysis of PET/CT to predict the
overall survival (OS) of PDAC patients. They reviewed the pre-
treatment PET/CT results from 139 patients with locally
advanced PDAC who had received stereotactic radiation therapy
and defined and extracted 5 categories of 173 radiomic features
and correlated these with OS and used the findings to propose a
prognostic imaging signature (imaging biomarker). When
validating their findings Cui et al found that only the proposed
signature was significant correlated with OS, contrasting with
conventional imaging modalities and clinical factors. Kaissis
et al[50] also developed an accurate model to predict OS (AUC=
0.9) based on information about a patients prognosis and their
radiomic features onMRI. They demonstrated that their machine
learning model based on preoperative diffusion-weighted imag-
ing for the prediction of survival correlated with the tumour
histopathological subtype in PDAC explaining the model’s ability
to predict prognosis. The results from these studies demonstrated
to clinicians that radiomic analysis could be used as an accurate,
non-invasive method to acquire basic pathological information.
In addition, the necessary comprehensive preoperative assess-
ment will reassure physicians that they are safely able to perform
less aggressive treatments in certain patients, ensuring the
important balance that is so important in patients with PDAC,
between OS and quality of life.
Nasief et al[51] analysed CT images from 90 patients who had
received CT-guided-chemoradiation therapy, and extracted the
baseline radiomic features and the changes induced by
treatment. By employing a machine learning based model,
Nasief et al found that variations in 13 radiomic features were
significantly correlated with the pathological response. Further
validation revealed that the optimized model performed well
(AUC=0.9) and was able to accurately predict whether the
patient would derive benefit from chemoradiation therapy, and
the AUC reached 0.94. These findings allow physicians to
employ novel radiomic biomarkers to select the patients who
will benefit maximally from individualised risk-adaptive
therapy.
Barriers to acceptance and the future of AI in
pancreatic cancer
The development of AI architectures and algorithms together
with the clinical demand for better tools to investigate, diagnose
andmonitor the treatment of patients with PDAC has been one of
the main drivers for the investigation of the clear potential of AI
systems in clinical practice. Studies have clearly demonstrated the
value of AI-based radiomic analysis, the information fromwhich,
through quantitative and weighted analytical methods can
significantly augment even expert clinical opinion. The added
value from the AI input improves the accuracy of diagnoses
in patients with PDAC in an efficient manner and provides
invaluable prognostic data.
A number of factors have contributed to the dramatic progress
of AI in the management of patients with PDAC including the
optimisation of algorithms, increasing computing power, the
expansion of training sets and the processing speed and accuracy
of AI analysis. Nevertheless, when dealing with complex systems,
all decisions are associatedwith a degree of uncertainty. This is an
issue widely recognised in medical applications and the principle
sources of these uncertainties are often categorised as epistemic or
aleatoric.
Epistemic uncertainty (derived from the Greek for knowledge
and -logy concerned with knowledge) is due to the physical
attributes of the system being analysed. It derives from a lack of
knowledge resulting from inadequate understanding of the
underlying processes, incomplete knowledge of the phenomena,
or imprecise evaluation of the related characteristics. Epistemic
uncertainty is generally caused by limited training data, and it
arises when a model encounters input data that differs from
training set. It is possible to reduce epistemic uncertainty with
increased amounts of training data but never eradicate it
completely. Aleatoric uncertainty (derived from the Latin alea
meaning dice alludes to the chance nature of the problem) refers
to unknown effects that influence an experiment each time it is
performed. The aleatoric uncertainty is the result of inherent data
noise and cannot be reduced even if more data is available. In
real-life epistemic and aleatoric uncertainty can occur together in
a single model and it can be difficult to identify their individual
contributions. To date, most state-of-the-art models studying the
pancreas only report variance of model performance over
multiple runs rather than investigating such uncertainties on
model outputs, but it is an active research area and methods such
as Bayesian statistics have shown promising results in assessing
and analysing them.[52,53] Epistemic uncertainty is the main
concern for current DL-based models used for imaging in the
medical field, as the quantity of data in both image and text
modalities is much less than other disciplines.[54,55]
Although there are rapidly increasing demands on radiology
services it is presently not possible to consider the use of AI as a
stand-alone service. Nevertheless, if progress continues at the
present rate AI models will become more anthropomorphic
increasing clinical acceptance and as a consequence utilisation.
This will inevitably improve clinical efficiency but should also
reduce the inter-individual differences among physicians caused
by different levels of personal experience and exposure to disease
spectra and hopefully facilitate the ultimate goal of individualized
medicine.
The clinical application of AI should be problem orientated,
reflecting the continued need for close cooperation between
clinicians and computer professionals involved in the develop-
ment and implementation of AI technologies. Barriers, particu-
larly to the integration and implementation of AI in the
management of all tumours including PDAC remain and one
of the most difficult to overcome is the mistrust of AI systems that
result primarily from clinicians lack of understanding of the
underlying technology.
A number of studies have demonstrated the potential for AI
based systems to provide non-invasive information reliably and
cost effectively. Coroller et al[56] performed radiomic analysis to
obtain phenotypic information of tumours and to predict the
likelihood of distant metastasis in patients with lung cancer and
Aerts et al[57] found that the gene-expression patterns of tumours
could also be revealed from radiomic features conferring
decision-support at reduced cost. Springer et al[58] developed a
machine learning based comprehensive system, which would
spare the unnecessary resection of cystic pancreatic lesions and
Pan et al[59] used fluorescent signals from cancer cells to define the
organotrophic pattern of PDACs, and evaluated the bio-
distribution of therapeutic antibodies. These approaches are
encouraging, and clinicians are increasingly looking for those
clinical areas whichwill benefit from the incorporation of the new
and rapidly evolving AI models.
Continued development clearly also requires the continued
enthusiasm and collaboration of computer professionals who are
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able to understand the underlying clinical issues and the
sensitivity required of AI imaging modalities to address the
nuances of cancer management particularly in patients with
PDAC. Computer professionals and software engineers are
essential to implement the necessary iterations and adaptations in
algorithms used in AI models and many problems can only be
overcome using mathematical and statistical methods. The
practical effects of lab-validated models remain uncertain, and
the complete replacement of human physicians by AI might
still be unacceptable in the present ethical and medico-legal
environment.
The potential value of AI in all fields of medicine is enormous
and models and approaches which were ubiquitously believed to
be highly subjective are increasingly accepted and recognised as
valuable tools in the armamentarium of clinicians dealing with
patients with malignancies particularly those where imaging is
generally complex and requires time and considerable resources.
In these patients by definition a definitive diagnosis is often
delayed which limits the opportunity for potentially curative
treatment. The development of increasingly sensitive, reliable and
cost-effective AI models is not possible without sufficiently large
and accurate data sets but fortunately these are becoming more
widely available and national and international collaborative
projects continue to expand the breadth and detail of the data
available to train AI models. It is inevitable that developments in
AI will change clinical practice supporting clinicians in their
decision-making processes, allowing them to work more
efficiently and ensuring patients receive individualised treatment
and better surveillance to ensure an optimal management and
outcome.
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